Work

A phase II trial of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer

Year: 2019

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2019.04.056

Authors: E. Zsiros, P.J. Frederick, S.N. Akers, K. Attwood, K. Wang, S.B. Lele, K. Odunsi

Institution: Roswell Park Comprehensive Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2955375583

FWCI: 3.187

Cites:

Cited by: 17

Related to: 10